Cargando…

An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer’s disease

Mutations leading to premature termination codons in ATP-Binding Cassette Subfamily A Member 7 (ABCA7) are high penetrant risk factors of Alzheimer’s disease (AD). The influence of other genetic variants in ABCA7 and downstream functional mechanisms, however, is poorly understood. To address this kn...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Roeck, Arne, Duchateau, Lena, Van Dongen, Jasper, Cacace, Rita, Bjerke, Maria, Van den Bossche, Tobi, Cras, Patrick, Vandenberghe, Rik, De Deyn, Peter P., Engelborghs, Sebastiaan, Van Broeckhoven, Christine, Sleegers, Kristel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954066/ https://www.ncbi.nlm.nih.gov/pubmed/29589097 http://dx.doi.org/10.1007/s00401-018-1841-z

Ejemplares similares

Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation
por: Van den Bossche, Tobi, et al.
Publicado: (2016)

Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)

The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics
por: De Roeck, Arne, et al.
Publicado: (2019)

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response
por: Duchateau, Lena, et al.
Publicado: (2023)

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
por: Goossens, Joery, et al.
Publicado: (2018)

Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015)

TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
por: van der Zee, Julie, et al.
Publicado: (2011)

Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
por: De Roeck, Arne, et al.
Publicado: (2017)

The Cerebrospinal Fluid Aβ(1–42)/Aβ(1–40) Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting
por: Niemantsverdriet, Ellis, et al.
Publicado: (2017)

Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk
por: Bettens, Karolien, et al.
Publicado: (2012)

No added diagnostic value of non-phosphorylated tau fraction (p-tau(rel)) in CSF as a biomarker for differential dementia diagnosis
por: Goossens, Joery, et al.
Publicado: (2017)

NanoSatellite: accurate characterization of expanded tandem repeat length and sequence through whole genome long-read sequencing on PromethION
por: De Roeck, Arne, et al.
Publicado: (2019)

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability
por: Cacace, Rita, et al.
Publicado: (2019)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

Rare missense mutations in ABCA7 might increase Alzheimer’s disease risk by plasma membrane exclusion
por: Bossaerts, Liene, et al.
Publicado: (2022)

Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects
por: Somers, Charisse, et al.
Publicado: (2019)

The genetics and neuropathology of frontotemporal lobar degeneration
por: Sieben, Anne, et al.
Publicado: (2012)

Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
por: Sieben, Anne, et al.
Publicado: (2018)

Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum
por: Gossye, Helena, et al.
Publicado: (2022)

The genetic landscape of Alzheimer disease: clinical implications and perspectives
por: Van Cauwenberghe, Caroline, et al.
Publicado: (2016)

Current status on Alzheimer disease molecular genetics: from past, to present, to future
por: Bettens, Karolien, et al.
Publicado: (2010)

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson’s disease
por: Smolders, Stefanie, et al.
Publicado: (2021)

A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease
por: Verheijen, Jan, et al.
Publicado: (2016)

Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains
por: Janssens, Jonathan, et al.
Publicado: (2015)

Rare Variants in PLD3 Do Not Affect Risk for Early‐Onset Alzheimer Disease in a European Consortium Cohort
por: Cacace, Rita, et al.
Publicado: (2015)

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort
por: Van Mossevelde, Sara, et al.
Publicado: (2016)

The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications
por: Gossye, Helena, et al.
Publicado: (2019)

Lack of association between bridging integrator 1 (BIN1) rs744373 polymorphism and tau‐PET load in cognitively intact older adults
por: Schaeverbeke, Jolien, et al.
Publicado: (2022)

Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
por: Gijselinck, Ilse, et al.
Publicado: (2015)

Diffusion Kurtosis Imaging: A Possible MRI Biomarker for AD Diagnosis?
por: Struyfs, Hanne, et al.
Publicado: (2015)

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers()
por: Adamczuk, Katarzyna, et al.
Publicado: (2013)

Brief cognitive screening instruments for early detection of Alzheimer’s disease: a systematic review
por: De Roeck, Ellen Elisa, et al.
Publicado: (2019)

Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation†
por: Zhou, Lujia, et al.
Publicado: (2011)

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline
por: Nous, Amber, et al.
Publicado: (2021)

VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer
por: Payavula, Harshitha Yadav, et al.
Publicado: (2023)

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites
por: Brouwers, N, et al.
Publicado: (2012)

Structural variants identified by Oxford Nanopore PromethION sequencing of the human genome
por: De Coster, Wouter, et al.
Publicado: (2019)

Improved Alzheimer’s Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study
por: Laton, Jorne, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018)

An intronic ABCA3 mutation responsible for respiratory disease
por: Agrawal, Amit, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9sjd6ktn8cjrq5a60ngkt0iogf